DOWNSTREAM ASSAYS NEWS

• Improving The Validity Of High Throughput Screening Assays

  Artel is launching the first in a new line of 100% DMSO-based Sample Solutions for use with the MVS® Multichannel Verification System. These will provide users with the ability to measure the accuracy and precision of volumes of DMSO dispensed into microwell plates.

• SAGE® Labs, Ekam Imaging, Inc. Partner To Develop Preclinical Imaging Assays To Screen Therapies Of Neurodegenerative Disease

  Sigma-Aldrich^® Corporation (Nasdaq: SIAL) today announced that Sigma Advanced Genetic Engineering (SAGE) Labs, an initiative of Sigma^®Life Science, and Ekam Imaging, Inc. have partnered to develop a suite of preclinical services based on the advanced translational power of genetically engineered rat models from SAGE Labs and Ekam's expertise in functional magnetic resonance imaging (fMRI) technology. For more information on SAGE Labs, visit www.sageresearchmodels.com

• FDA Inspects MicroConstants For Compliance With Good Laboratory Practices, No Deficiencies Noted

  Bioanalytical and pharmacokinetic specialty Contract Research Organization (CRO) MicroConstants announced today the successful completion of a five-day inspection by the United States Food and Drug Administration (FDA) for compliance with Good Laboratory Practice (GLP) regulations.

• New Molecular Assay Allows Healthcare Facilities To Simplify Active Surveillance Testing for Deadly Superbug

  BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced that the new BD MAX™ MRSA molecular test has received a Moderate Complexity rating under the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88). Performed on the fully-automated BD MAX™ System, the assay is designed to rapidly and accurately identify patients colonized with methicillin-resistant Staphylococcus aureus (MRSA).

• Absorption Systems Announces Novel Test Platform For Interactions With The BCRP Transporter

  Absorption Systems, a world leader in developing novel test systems for drug transporters, announces the availability of a long-awaited assay platform for the human BCRP transporter, also known as breast cancer resistance protein. 

• Roche Submits TnT-hs Assay To FDA For Clearance On The Cobas Immunoassay And Elecsys Analyzers

  Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has filed a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a fully automated TnT-hs assay for use on Roche's full portfolio of laboratory analyzers.

• New Study Shows Adaptive Biotechnologies immunoSEQ Assay Significantly More Sensitive Than Traditional Method To Detect Minimal Residual Disease In Leukemia

  Adaptive Biotechnologies Corporation, a leading provider of next-generation sequencing assays for the adaptive immune system, announced today results from the first head-to-head comparison of high throughput sequencing (HTS) using immunoSEQ™ and traditional flow cytometry. 

• Southern Research And Galveston National Laboratory To Develop High-Throughput Screening Platform In Biosafety Level-4 Laboratory

  Southern Research today announced that it will collaborate with the University of Texas Medical Branch at Galveston to develop and validate a high-volume, high-throughput screening platform in their Galveston National Laboratory (GNL).